cosmos health inc - COSM

COSM

Close Chg Chg %
0.27 -0.02 -7.42%

Closed Market

0.25

-0.02 (7.42%)

Volume: 1.73M

Last Updated:

Jun 5, 2026, 4:00 PM EDT

Company Overview: cosmos health inc - COSM

COSM Key Data

Open

$0.28

Day Range

0.25 - 0.28

52 Week Range

0.25 - 1.32

Market Cap

$16.19M

Shares Outstanding

59.96M

Public Float

33.22M

Beta

4.12

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.65

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.37M

 

COSM Performance

1 Week
 
9.68%
 
1 Month
 
-18.48%
 
3 Months
 
-26.82%
 
1 Year
 
-42.97%
 
5 Years
 
-99.77%
 

COSM Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About cosmos health inc - COSM

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

COSM At a Glance

Cosmos Health, Inc.
5 Agiou Georgiou Street
Thessaloniki, Central Macedonia 554 38
Phone 30-312-865-0026 Revenue 65.27M
Industry Pharmaceuticals: Major Net Income -19,144,998.00
Sector Health Technology 2025 Sales Growth 19.927%
Fiscal Year-end 12 / 2026 Employees 163
View SEC Filings

COSM Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.231
Price to Book Ratio 1.11
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -2.165
Enterprise Value to Sales 0.503
Total Debt to Enterprise Value 0.647

COSM Efficiency

Revenue/Employee 400,440.583
Income Per Employee -117,453.975
Receivables Turnover 2.836
Total Asset Turnover 1.088

COSM Liquidity

Current Ratio 1.003
Quick Ratio 0.852
Cash Ratio 0.092

COSM Profitability

Gross Margin 9.999
Operating Margin -25.341
Pretax Margin -29.331
Net Margin -29.331
Return on Assets -31.899
Return on Equity -89.134
Return on Total Capital -48.24
Return on Invested Capital -74.719

COSM Capital Structure

Total Debt to Total Equity 115.401
Total Debt to Total Capital 53.575
Total Debt to Total Assets 32.352
Long-Term Debt to Equity 33.788
Long-Term Debt to Total Capital 15.686
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cosmos Health Inc - COSM

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
50.35M 53.38M 54.43M 65.27M
Sales Growth
-10.48% +6.02% +1.97% +19.93%
Cost of Goods Sold (COGS) incl D&A
44.58M 49.64M 51.36M 58.75M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
188.89K 614.38K 1.25M 1.37M
Depreciation
155.81K 376.73K 416.92K 444.24K
Amortization of Intangibles
33.09K 239.84K 832.32K 925.11K
COGS Growth
-7.82% +11.36% +3.47% +14.37%
Gross Income
5.77M 3.74M 3.06M 6.53M
Gross Income Growth
-26.81% -35.24% -18.02% +113.13%
Gross Profit Margin
+11.46% +7.00% +5.63% +10.00%
2022 2023 2024 2025 5-year trend
SG&A Expense
13.24M 25.57M 18.31M 23.07M
Research & Development
- - 533.29K 519.36K
-
Other SG&A
13.24M 25.57M 17.78M 22.55M
SGA Growth
+6.67% +93.07% -28.36% +25.95%
Other Operating Expense
- - - -
-
Unusual Expense
(985.54K) (3.36M) 289.51K 484.36K
EBIT after Unusual Expense
(6.49M) (18.47M) (15.54M) (17.03M)
Non Operating Income/Expense
(2.60M) 795.86K 371.66K 502.81K
Non-Operating Interest Income
236.35K 662.86K 406.45K 396.41K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
3.97M 866.48K 1.01M 2.62M
Interest Expense Growth
+10.73% -78.15% +16.83% +159.07%
Gross Interest Expense
3.97M 866.48K 1.01M 2.62M
Interest Capitalized
- - - -
-
Pretax Income
(13.06M) (18.54M) (16.18M) (19.14M)
Pretax Income Growth
-66.36% -42.03% +12.73% -18.30%
Pretax Margin
-25.93% -34.74% -29.73% -29.33%
Income Tax
- - - 775.05K
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - (75.72K)
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - 850.77K
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(13.83M) (18.54M) (16.18M) (19.14M)
Minority Interest Expense
- - - -
-
Net Income
(13.83M) (18.54M) (16.18M) (19.14M)
Net Income Growth
-73.71% -34.07% +12.73% -18.30%
Net Margin Growth
-27.47% -34.74% -29.73% -29.33%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(13.83M) (18.54M) (16.18M) (19.14M)
Preferred Dividends
- 50.11M 7.24M 6.20M
Net Income Available to Common
(63.95M) (25.78M) (22.38M) (19.14M)
EPS (Basic)
-33.1637 -2.1543 -1.1687 -0.6321
EPS (Basic) Growth
-39.70% +93.50% +45.75% +45.91%
Basic Shares Outstanding
1.93M 11.97M 19.15M 30.29M
EPS (Diluted)
-33.1637 -2.1543 -1.1687 -0.6321
EPS (Diluted) Growth
-39.70% +93.50% +45.75% +45.91%
Diluted Shares Outstanding
1.93M 11.97M 19.15M 30.29M
EBITDA
(7.29M) (21.22M) (14.00M) (15.17M)
EBITDA Growth
-78.40% -191.23% +34.00% -8.34%
EBITDA Margin
-14.47% -39.75% -25.73% -23.24%

Snapshot

Average Recommendation BUY Average Target Price 3.00
Number of Ratings 1 Current Quarters Estimate 0.01
FY Report Date 06 / 2026 Current Year's Estimate 0.01
Last Quarter’s Earnings -0.06 Median PE on CY Estimate N/A
Year Ago Earnings -0.63 Next Fiscal Year Estimate 0.07
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate 0.01 0.02 0.01 0.07
High Estimates 0.01 0.02 0.01 0.07
Low Estimate 0.01 0.02 0.01 0.07
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Cosmos Health Inc - COSM

Date Name Shares Transaction Value
Feb 13, 2026 Grigorios Siokas Chief Executive Officer; Director 8,473,382 Open market or private purchase of non-derivative security Non-derivative transaction at $0.41 per share 3,474,086.62

Cosmos Health Inc in the News